HomeProductAntidiabetic AgentsAntidiabetic Agents

DIAMICRON MR

DIAMICRON MR

Code : DIA04

Price: Contact

Manufacturer                          
  •       SERVIER
1r
Present/Packing          Diamicron MR modified-release tablet - Diamicron MR 60 mg x 2 blisters x 30's
Price                    

Features  
 

Delivery



Share this product to others

Shopping
guide
Add to cart

DIAMICRON MR

Manufacturer:

          Servier

Contents:

          Gliclazide

Indications:

          Treatment of type II diabetes in association w/ dietary measures & physical exercise, when these measures alone are inadequate to control blood glucose.

Contraindications:

          Hypersensitivity to other sulfonylureas or sulfonamides. Type I diabetes; diabetic ketoacidosis, pre-coma & coma; severe renal or hepatic insufficiency. Concomitant treatment w/ miconazole. Rare hereditary problems of galactose intolerance, glucose-galactose malabsorption or Lapp lactase deficiency. Pregnancy & lactation.

Special Precautions:

          Patients who are undernourished or w/ poor general health; adrenal insufficiency or hypopituitarism; on β-blocker therapy. Discontinue treatment & administer insulin in patients w/ fever, trauma, infection or surgical intervention. Long-term use. G6PD-deficiency. May impair ability to drive or operate machinery. Elderly.

Dosage:

          Usual dose: ½-2 tab/day as single dose. Max: 2 tab/day. Previously untreated patient Initially ½ tab. Patient whose blood glucose levels do not decrease after 2-wk treatment Dose may be increased at the end of 2nd-wk treatment.

Class:

          Antidiabetic Agents

Presentation/Packing:

          Diamicron MR modified-release tablet - Diamicron MR 60 mg x 2 blisters x 30's

Details:

          MyPhuocPharmacy – (08) 62581003

Gliclazide
Usual dose: ½-2 tab/day as single dose. Max: 2 tab/day. Previously untreated patient Initially ½ tab. Patient whose blood glucose levels do not decrease after 2-wk treatment Dose may be increased at the end of 2nd-wk treatment.
Updating
Patients who are undernourished or w/ poor general health; adrenal insufficiency or hypopituitarism; on β-blocker therapy. Discontinue treatment & administer insulin in patients w/ fever, trauma, infection or surgical intervention. Long-term use. G6PD-deficiency. May impair ability to drive or operate machinery. Elderly.

Rating

(based on 0 rating)

We want to know your comment!


Write a review


     
  Rating
  Email *
  Fullname *
  Title *
  Content *
  Confirm code *